This study aims to further validate the effectiveness of bimagrumab in maintaining lean body mass while optimizing weight loss and to explore the safety and efficacy of its combined use with the GLP-1 receptor agonist semaglutide
The debilitating, slow damage created by high levels of blood sugar (glucose) destroys everything from your blood vessels to your eyes, kidneys, and nerves over time due to oxidative stress (remember the free radicals or reactive oxygen species (ROS)?)
Any reaction that is clearly worsening at 48 hours needs medical evaluation
Vials with rubber stoppers and flip-off caps do not pose the same glass fragment risk
Garber A, Henry R, Ratner R, et al, for the LEAD-3 (Mono) Study Group
For those already researching GLP-1 based therapies, guides on the relationship between GLP-1 and Ozempic and GLP-1 companion resources provide additional metabolic context